<unk> (injection) is an carbonic anhydrase inhibitor that is FDA approved for the treatment of edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma.   Common adverse reactions include paresthesias, tinnitus, loss of appetite, taste alteration, nausea, vomiting, diarrhea, polyuria, drowsiness, and confusion.
Acetazolamide 
Mannitol
Tacalcitol
Brinzolamide
Timolol 
Manidipine
Chlorthalidone
Tropicamide